Oncologists near Elmhurst, NY

Biography: Dr. Christian Rolfo, MD is an Oncology Specialist who practices in New York, NY. Dr. Christian Rolfo, MD is affiliated with Mount Sinai Morningside, Mount Sinai Queens and Mount Sinai Brooklyn.

Biography: Dr. John Levine, MD is an Oncology Specialist who practices in New York, NY. He is 62 years old and has been practicing for 36 years. Dr. John Levine, MD is affiliated with Mount Sinai Hospital.

Biography: Dr. Cardinale Smith, MD is a Geriatrician who practices in New York, NY. She is 47 years old and has been practicing for 22 years. Dr. Cardinale Smith, MD is affiliated with Mount Sinai Hospital and Mount Sinai Queens.

Biography: Dr. Larysa Sanchez, MD is an Oncology Specialist who practices in New York, NY. She is 38 years old. Dr. Larysa Sanchez, MD is affiliated with Mount Sinai Queens, Mount Sinai Brooklyn and Mount Sinai Morningside.

Biography: Nausheen Hakim, DO, is a hematologist and oncologist at NewYork-Presbyterian Medical Group Queens, affiliated with NewYork-Presbyterian Queens Hospital. She is an assistant professor of clinical medicine at Weill Cornell Medicine. Dr. Hakim has a special interest in the area of genitourinary cancers. Active in research, Dr. Hakim has published in several medical journals, as well as delivered presentations at the American Society of Clinical Oncology and the World Lung Conference. After obtaining her bachelor of arts in anthropology while pursuing the pre-medicine track, she volunteered for one year with AmeriCorps at the nonprofit South Asian Youth Action (SAYA). She graduated from New York College of Osteopathic Medicine and completed her internal medicine residency at Drexel University/Hahnemann Hospital in Philadelphia. She served her hematology and medical oncology fellowship at the Northwell Health Cancer Institute. Dr. Hakim remains dedicated to the world of nonprofit by participating on the advisory board of Unite for Health. With a commitment to working in global health, she strives to better understand palliative care barriers in not only communities abroad, but in our own communities here in Queens.

Biography: Caitlin Gribbin, MD, is an Instructor in Medicine within the Division of Hematology and Oncology at Weill Cornell Medical Center. After earning her B.A. from Cornell University, Dr. Gribbin received her Medical Degree as well as Masters in Science from Weill Cornell Medical College. She completed her Internship and Residency as well as subsequent Fellowship training in Hematology and Oncology within the Medical Research Track at Weill Cornell Medicine/NewYork-Presbyterian Hospital. As a faculty member at Weill Cornell, Dr. Gribbin specializes in treating patients with lymphoma using cellular therapies, including chimeric antigen receptor (CAR) T cell therapy. She is simultaneously focused on leading clinical and translational research studies aimed at improving lymphoma treatments by bringing novel scientific discoveries to patients. Dr. Gribbin has co-authored numerous publications and presentations at national and international meetings and has received several research grants, including the American Society of Clinical Oncology (ASCO) Young Investigator Award, the Lymphoma Research Foundation (LRF) Scientific Research Mentoring Program Award, and the Burroughs Wellcome Fund Award.

Biography: Ms. Kleinert received her Doctor of Nursing Practice (DNP) degree at Case Western Reserve University and her Pediatric Nurse Practitioner (PNP) degree at New York University, where she also received her MA degree in Adult Primary Care. She has also completed her Master of Public Health degree (MPH) at Columbia University.

Care Philosophy: Alexander J. Chou, MD, is a pediatric oncologist specializing in the treatment of pediatric sarcomas, rare cancers of the bone and soft tissues at Children's Hospital at Montefiore. Dr. Chou, along with his colleagues, provides state-of-the-art therapies to patients with sarcomas in a comprehensive and multidisciplinary setting. Dr. Chou is the Clinical Director of the Pediatric Sarcoma Service at the Children's Hospital at Montefiore and an Associate Professor of Pediatrics at the Albert Einstein College of Medicine.Dr. Chou earned his Bachelor of Arts in Biology in 1994 at the University of Pennsylvania. In 1998, he received his Doctor of Medicine at Cornell University Medical College in New York City. Following this, he completed an internship and residency in Pediatrics at New York-Presbyterian Hospital/Weill Cornell Medical Center in New York City.

Biography: Maria is a Pediatric Hemophilia Nurse Practitioner at Weill Cornell Medicine, bringing over nine years of nursing experience to her role. She began her journey at Quinnipiac University, where she graduated with honors in nursing, and then joined Memorial Sloan Kettering Cancer Center, caring for oncology patients. While working full-time as an RN, Maria pursued her master's degree at Pace University, earning her Family Nurse Practitioner (FNP) certification. Her extensive experience and dedication make her an asset in the field of pediatric hemophilia care.

Biography: Hanna Rosen, NP is an Oncology Specialist who practices in New York, NY. Hanna Rosen, NP is affiliated with Weill Cornell Medical Center.

Biography: Dr. Ferrarone graduated medical school from New York Medical College. He completed both his residency in internal medicine and his fellowship in medical oncology at Weill Cornell Medicine and NewYork-Presbyterian Hospital. After his fellowship, Dr. Ferrarone received training in cancer biology research under the guidance of the Nobel laureate Dr. Harold Varmus. Dr. Ferrarone's clinical and research efforts are focused on lung cancer. In his laboratory, he studies how mutations in certain genes influence the growth of tumors and their interaction with the immune system. The aim of his research is to provide new insights into the behavior of lung cancer, to enable the development of new cancer treatments and the rational design of clinical trials.

Biography: Dr. Laura S. Munoz Arcos is an Assistant Professor of Medicine in the Division of Hematology and Medical Oncology at Weill Cornell Medicine and an Assistant Attending Physician at NewYork-Presbyterian Hospital.Dr. Munoz Arcos earned her medical degree from Universidad del Valle in Colombia, her home country. She then completed an internal medicine residency at Montefiore Medical Center/Albert Einstein College of Medicine in the Bronx, NY, followed by a Hematology and Oncology fellowship at Weill Cornell Medicine/NewYork-Presbyterian Hospital, where she served as Chief Fellow in her final year. During her fellowship, Dr. Munoz Arcos gained extensive clinical experience in treating all types of breast cancer while conducting translational research on liquid biopsy in breast cancer at Dr. Massimo Cristofanilli's laboratory. Her research focuses on identifying predictors of response to therapy in hormone receptor-sensitive metastatic breast cancer. In recognition of her work, she received the 2023 Conquer Cancer American Society of Clinical Oncology (ASCO) Young Investigator Award, a prestigious honor granted to only 100 recipients annually. Following the completion of her fellowship, Dr. Munoz Arcos joined the Division of Hematology and Medical Oncology as a faculty member, where she is focused on the treatment of breast cancer.

Biography: Ashley Schreier, D.O., is an Assistant Professor of Medicine within the Division of Hematology and Medical Oncology at Weill Cornell Medicine, and Assistant Attending physician at NewYork-Presbyterian Hospital. Dr. Schreier treats patients with all forms of breast cancer. She has a special interest in caring for those with triple negative breast cancer (TNBC), which has been the emphasis of her research.Dr. Schreier received her B.S. in 2012 from Cornell University. She then entered medical school at NYIT College of Osteopathic Medicine. During her time in medical school, Dr. Schreier was inducted into the Osteopathic Scholastic Honor Society and Service Fraternity as well as the Gold Humanism Honor Society. She also received the Glasgow Rubin Achievement Award, a prestigious honor reserved for those who graduate in the top 10% of their medical school class. After graduating medical school in 2017, Dr. Schreier began her residency in Internal Medicine at the Albert Einstein College of Medicine/Montefiore Medical Center where she was awarded the Outstanding House Officer in Ambulatory Care Medicine Award as well as the Barry Mishkin Award for Humanity, Ethics, and Excellence in the Practice of Medicine. She continued her medical training at Weill Cornell Medicine and NewYork-Presbyterian (WCM/NYP) with a fellowship in Hematology and Medical Oncology. During her fellowship at WCM/NYP, Dr. Schreier focused her clinical efforts within the field of breast oncology and became involved in research projects in TNBC. Her main research focus has been developing a translational research pipeline through her collaboration with Dr. Roberta Zappasodi's laboratory and focusing on novel immunotherapy strategies in breast cancer.

Biography: Dr. Vered Stearns completed the equivalent of a B.S. degree at the Tel Aviv University, Sackler Faculty of Medicine in 1989. After relocating to the United States, Dr. Stearns transferred to and graduated from the University of Medicine and Dentistry of New Jersey, Robert Wood Johnson Medical School with a medical degree (M.D.) in 1992. She completed a residency in Internal Medicine and a fellowship in Medical Oncology at the Georgetown University where she developed an interest in translational breast cancer research and spent two additional years as a research fellow. Dr. Stearns was a faculty member at the Lombardi Comprehensive Cancer Center and the Georgetown University, and at the University of Michigan Comprehensive Cancer Center in Ann Arbor, Michigan before joining the Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins in 2002. She remained at Johns Hopkins and served in a variety of roles, including co-Director of the Breast Cancer Program, co-Director of the Breast and Ovarian Cancer Program, Director, Women's Malignancies Disease Group and inaugural Medical Director of the Under Armour Breast Health Innovation Center, until being recruited to Weill Cornell Medicine and New York-Presbyterian Hospital in 2023. At Weill Cornell Medicine, Dr. Stearns is Director of Translational Breast Cancer Research at the Department of Medicine, and Associate Director for Clinical Services at the Meyer Cancer Center. Her role in the Meyer Cancer Center will allow her to develop programs and to mentor team members across diseases throughout Manhattan, Brooklyn and Queens.Dr. Stearns's long-term research goal is to improve current therapies by individualizing strategies for the treatment and prevention of breast cancer. The main focus of Dr. Stearns's research includes the utilization of biomarkers to predict response to standard regimens used to treat and prevent breast cancer, and to introduce new interventions. Dr. Stearns and colleagues from the Consortium On Breast Cancer Pharamcogenomics (COBRA) Group were the first to evaluate the role of genetic variants in candidate genes such as CYP2D6 in tamoxifen metabolism, safety, and efficacy. This work has been extended to evaluate the role of genetic variants in aromatase inhibitor associated outcomes. She has also conducted clinical investigations of epigenetic modifying agents across the breast cancer continuum. She is evaluating whether histone deacetylase inhibitors enhance response to immunotherapy. Having demonstrated that methylation markers predict breast cancer risk, she is evaluating whether natural compounds can reverse these modifications.Dr. Stearns has received numerous grants and awards to fund her innovative research. She was a recipient of early career awards including a Clinical Research Training Grant from the American Cancer Society, and was one of the first five recipients of the prestigious Damon Runyon Clinical Investigator Award. Subsequently she was the inaugural recipient of the American Society of Clinical Oncology (ASCO) Advanced Clinical Research Award.She served as a Board Member of the National Accreditation Program for Breast Centers (NAPBC) for the American College of Surgeons (ACS), and was elected in 2020 as Fellow of the American Society of Clinical Oncology (FASCO). Her work has already had a positive impact on the lives of many women, and in 2017, Dr. Stearns was selected by Forbes as one of 27 top breast cancer oncologists in the United States. Dr. Stearns is Vice Chair of the NRG Translational Science Committee, and Co-Chair of the NRG Breast?Translational?Working Group. In these roles, she works closely with Group members as they investigate correlative biomarkers obtained through breast cancer trials.

Biography: Amanda earned her Master's degree in genetic counseling at the Icahn School of Medicine at Mount Sinai, and her passion for identifying those at risk for hereditary cancer began early in her career. Educating future genetics providers has also been important to her, so she has served a clinical rotation supervisor, thesis advisor and adjunct professor focusing on hereditary cancer. Amanda has held management roles for genetics services in community medicine, telemedicine, and commercial laboratories before joining the Weill Cornell Medicine as the Clinical Operations Administrator for the Genetics and Personalized Cancer Prevention Program.

Biography: Manuel Hidalgo, M.D., Ph.D., is currently the Chief of the Division of Hematology and Medical Oncology at Weill Cornell Medicine/NewYork-Presbyterian Hospital. Dr. Hidalgo received his M.D. from the University of Navarra in Pamplona, Spain in 1992, and Ph.D. from University Autonoma of Madrid in 1997. He trained in medicine and medical oncology at Hospital "12 de Octubre" in Madrid and at the University of Texas Health Science Center in San Antonio, Texas. He also completed a fellowship program in anticancer drug development at the Institute of Drug Development in San Antonio. Prior to this position, he served as an Assistant Professor of Medicine at the Division of Hematology and Oncology at the University of Texas Health Science Center in San Antonio. In 2001, Dr. Hidalgo relocated to Johns Hopkins University to serve as Director of the Gastrointestinal Oncology Program at the Kimmel Comprehensive Cancer Center, where he also held the title of Associate Professor of Oncology. Dr. Hidalgo became Director of the Clinical Research Program at the Spanish National Cancer Center in 2009 and Vice Director of Translational Research in 2011. In 2015, he became the Chief of the Division of Hematology and Oncology and Director of the Rosenberg Clinical Cancer Center at the Beth Israel Deaconess Medical Center in Boston. Dr. Hidalgo also served as the Theodore W. and Evelyn G. Berenson Professor of Medicine at Harvard Medical School. His main focus of research has been new drug development in pancreatic cancer. His group popularized the use of Avatar mouse models for cancer research and recently contributed to the development and Federal Drug Administration (FDA) approval of nab-paclitaxel for pancreatic cancer treatment. Dr. Hidalgo's current research focuses on strategies for personalized medicine and immunotherapy in pancreatic cancer. Dr. Hidalgo also serves on the Board of Directors for Bristol Myers Squibb (BMS).

Biography: Brian Navarro, NP is an Oncology Specialist who practices in New York, NY. Brian Navarro, NP is affiliated with Newyork-Presbyterian/Columbia University Medical Center.

Biography: Dr. Dominder Kaur received her medical degree from Maharashtra University of Health Sciences, Nashik in India and completed her pediatric residency at Northwell Health Staten Island University Hospital in New York. She trained in pediatric hematology-oncology at the Mayo Clinic in Minnesota while also receiving a Masters in Clinical and Translational Science from the Mayo School of Graduate Medical Education. She received further specialized training as the Joan Wallick Pediatric Hemostasis Thrombosis fellow at the Nationwide Children's Hospital. She joined as faculty at Columbia University/Columbia Presbyterian Medical Center in December 2018 as an Assistant Professor in Pediatrics. Dr. Kaur was the recipient of the Thrombosis & Hemostasis Societies of North America (THSNA) 2018 Young Investigator Award. Her research focus so far has been on bleeding and thrombotic complications stem cell transplant recipients. She is currently working towards improving screening methodology and approaches to bleeding disorder evaluation in children. She is passionate about improving hematological services for young adults, especially young women with possible bleeding disorders. In collaboration with Adolescent Medicine team, Dr. Kaur staffs the Girls & Young-women's Bleeding Issues Clinic (GYBiC). This clinic is one of only two such centers in New York metropolitan area and offers hematological and adolescent medicine specialty consultations and evaluations in one comprehensive visit. The Girls & Young-women's Bleeding Issues Clinic specializes in the diagnosis and treatment of bleeding (like heavy periods/menorrhagia) and clotting disorders (thrombophilia) and accompanying health issues in young women of reproductive age.

Biography: Dr. Beth Popp, MD is an Oncology Specialist who practices in New York, NY. She is 63 years old and has been practicing for 37 years. Dr. Beth Popp, MD is affiliated with Mount Sinai Brooklyn and Mount Sinai Morningside.

Biography: Dr. Sheera Minkowitz, MD is an Oncology Specialist who practices in Brooklyn, NY. She is 39 years old and has been practicing for 13 years. Dr. Sheera Minkowitz, MD is affiliated with Newyork-Presbyterian.

Biography: Monica Bhatia, MD specializes in the care of children with noncancerous blood disorders who may benefit from bone marrow transplantation, especially sickle cell anemia. She and her colleagues are working to reduce the toxicity (side effects) and complications of this treatment without compromising its effectiveness, and to make it available to more patients. The field of pediatric hematology brings with it many intellectual challenges, and bone marrow transplantation in particular is especially dynamic. Dr. Bhatia has the opportunity to provide care for the sickest children, potentially curing their disease. She builds strong relationships with her patients and their families that last for years. It is inspiring for her to see young patients grow up to lead healthy, productive lives. NewYork-Presbyterian/Morgan Stanley Children's Hospital has a robust program for bone marrow transplantation for sickle cell anemia - the only cure for this disease. Dr. Bhatia and her team have witnessed remarkable results among children who are cured with bone marrow transplantation and spared from the potentially life-threatening complications of sickle cell disease. Yet despite the advances made, only 15 percent of patients with sickle cell disease have a matched sibling bone marrow donor. Therefore, Dr. Bhatia and her team conduct research to evaluate a procedure called "CD34-selected stem cell transplantation" to remove T-cells from donor bone marrow for patients without a matched sibling donor. This approach reduces the risk of graft-versus-host disease (GVHD), a potential complication of bone marrow transplantation in which T-cells from the donor attack the tissue of the recipient. This approach to harnessing stem cells could potentially make bone marrow transplantation a safer, effective option for many patients who are seeking a cure for sickle cell disease. Dr. Bhatia and her colleagues are currently assessing reduced-intensity transplantation, which uses lower doses of chemotherapy to decrease the risk of side effects and long-term complications without lowering the effectiveness of treatment. She is also interested in looking for ways to further improve the quality of life of patients who have had a bone marrow transplant in addition to fertility preservation.

Biography: Dr. Ryan Moy is an Assistant Professor of Medicine and medical oncologist at Columbia University Irving Medical Center where he specializes in the treatment of gastrointestinal malignancies, with a focus on esophageal and stomach cancers. He received his MD/PhD from the University of Pennsylvania and completed internship and residency training in Internal Medicine at NewYork-Presbyterian Hospital/Weill Cornell Medical Center. He then completed fellowship training in Medical Oncology at Memorial Sloan Kettering Cancer Center and postdoctoral research at The Rockefeller University. Dr. Moy is actively involved in translational research to understand the biological mechanisms that regulate metastasis, the primary driver of mortality in gastrointestinal cancers. He has performed laboratory-based research to define critical genes that promote liver metastasis in colorectal cancer. He is also conducting research to discover key vulnerabilities in esophageal and gastric cancers, with the goal of translating these findings from the lab to develop more effective treatments for patients. As an active member of the gastrointestinal oncology and experimental therapeutics groups, Dr. Moy is involved in developing and leading clinical trials investigating novel targeted and immunotherapy treatments for esophagogastric cancer and other malignancies. His work has been recognized by several awards including a Damon Runyon Cancer Research Foundation Fellow Award and a National Cancer Institute (NCI) K08 Career Development Award. Dr. Moy works as part of a multidisciplinary team with the mission of delivering compassionate and state-of-the-art oncologic care to each patient, using a precision medicine approach to provide innovative and promising treatments.

Biography: Neil Vasan, MD, PhD, is a physician-scientist in the Department of Medicine and the Herbert Irving Comprehensive Cancer Center at Columbia University Irving Medical Center. The Vasan Lab uses functional genomics to understand how oncoproteins regulate breast cancer cell signaling, growth, and therapeutic response. Dr. Vasan received his AB/AM from Harvard University and MD/PhD from Yale University School of Medicine, and completed clinical training in internal medicine at Massachusetts General Hospital and in medical oncology at Memorial Sloan Kettering Cancer Center. As a postdoctoral fellow, he identified doublePIK3CAmutations as an oncogenic alteration, which has gone from bench to bedside as a cancer genomic biomarker. His research awards include the NIH K08, Susan G. Komen Career Catalyst Research grant, American Association for Cancer Research (AACR) NextGen Star, andAmerican Society for Clinical Investigation (ASCI)Young Physician-Scientist Award.Dr. Vasan is an active clinical oncologist treating patients with breast cancerand serves as a standing member of the Oncologic Drugs Advisory Committee (ODAC) for the FDA.

Biography: Dr. Juan-Manuel Schvartzman, MD is an Oncology Specialist who practices in New York, NY. He is 46 years old and has been practicing for 23 years. Dr. Juan-Manuel Schvartzman, MD is affiliated with Newyork-Presbyterian.

Biography: Dr. Yoanna Pumpalova is an Assistant Professor of Medicine and medical oncologist at Columbia University Irving Medical Center where she specializes in the treatment of gastrointestinal malignancies, with a focus on colorectal and anal cancers. She received her MD from Weill Cornell Medical College and completed internship and residency training in Internal Medicine and Global Health at Stanford University. She then completed fellowship training in Medical Oncology at Columbia University/New York Presbyterian Hospital. Dr. Pumpalova works as part of a multidisciplinary team with the mission of delivering compassionate and state-of-the-art oncologic care to each patient, using a precision medicine approach to provide innovative and promising treatments. Dr. Pumpalova is actively involved in translational research to understand the biological mechanisms driving early onset colorectal cancer. She collaborates with Dr. Joel Gabre, a gastroenterologist and clinician scientist and Dr. Beatrice Dionigi, colorectal surgeon, on research to understand how early onset colorectal cancer differs from average onset colorectal cancer, with the goal of uncovering novel ways to treat all patients with colorectal cancer. Dr. Pumpalova is also the site principal investigator of industry-sponsored clinical trials investigating novel therapies for the treatment of colorectal cancer. Further, Dr. Pumpalova conducts studies in low- and middle-income countries focused on early detection and screening for colorectal cancer. She has active studies in South Africa and Dominican Republic. Her research goal is to improve outcomes for patients diagnosed with colorectal cancer, regardless of where they reside. Her work has been recognized by several awards including an ASCO Young Investigator Award and ASCO Career Development Award. In the NewsColumbia Researchers Seek Answers for Rise of Colon Cancer in Younger PatientsWhat to Know About the Rise of Colorectal Cancer in Younger PeopleExploring Strategies for Earlier Colon Cancer Detection in Sub-Saharan Africa

Biography: As an Assistant Professor of Medicine within the Division of Hematology/Oncology at Columbia University Irving Medical Center (CUIMC), Dr. McGuinness specializes in the care of patients with breast cancer or who are at high risk of developing breast cancer. She is currently involved in patient care, clinical research, and education. Her research interests include the evaluation of novel imaging-based tools to refine breast cancer risk prediction and to predict which patients receive benefit from breast cancer therapies. As part of this work, she collaborates closely with computer scientists, data scientists, and breast radiologists at Columbia. She also serves as the principal investigator for multiple clinical trials at CUIMC that evaluate novel treatments for patients with breast cancer. She is actively involved in the SWOG Cancer Research Network, and serves as a member of the SWOG Prevention and Epidemiology and Breast Committees, as well as the SWOG Breast Translational Medicine Working Group. Dr. McGuinness received her bachelor of arts in Biology magna cum laude from Williams College, and her medical degree with Honor from Baylor College of Medicine, where she was elected to the Gold Humanism Honor Society. She completed both her Internal Medicine residency and Hematology/Oncology fellowship at Columbia University Irving Medical Center, during which she also served as Chief Fellow and completed a Postdoctoral Research Fellowship in Biomedical Informatics. Dr. McGuinness is the recipient of multiple career development awards from the Conquer Cancer Foundation/American Society of Clinical Oncology and the Susan G. Komen Foundation, as well as a TRANSFORM KL2 Mentored Career Development Award.

Biography: Tiye Bhutia, NP is an Oncology Specialist who practices in New York, NY. Tiye Bhutia, NP is affiliated with Newyork-Presbyterian/Columbia University Medical Center.

Biography: Diana McDonnell, NP is an Oncology Specialist who practices in New York, NY. Diana McDonnell, NP is affiliated with Newyork-Presbyterian/Columbia University Medical Center.

Biography: Benjamin Izar, MD, PhD is an assistant professor of medicine at the Columbia Vagelos College of Physicians and Surgeons in the division of Hematology/Oncology and a member of the Tumor Biology and Microenvironment Program at the Herbert Irving Comprehensive Cancer Center. Dr. Izar's clinical practice focuses on melanoma and cancer immunotherapy. In his lab, Dr. Izar studies interactions between cancer cells and cells of the tumor-microenvironment, and how these define metastatic niches, response and resistance to cancer immunotherapies. His lab develops and uses cutting-edge single-cell genomics and genome-editing tools to study patient tumors and models at unprecedented resolution Dr. Izar received his MD/PhD at Justus Liebig University in Giessen, Germany, where he was graduated summa cum laude. He completed his internal medicine residency training at Massachusetts General Hospital and medical oncology training at Beth Israel Deaconess Medical Center, followed by his first faculty position at Danna-Farber Cancer Institute. He completed post-doctoral research training in cancer immunology at Dana-Farber Cancer Institute and the Broad Institute of MIT and Harvard. In addition to several awards he received during his training, Dr. Izar is the recipient of multiple national awards, including a NIH/NCI K08 Award (2017) and the prestigious Burroughs Welcome Fund Career Award for Medical Scientists (2018), and he was selected as a NextGen Star of the American Association for Cancer Research (2019). In 2020, he was selected as a Louis V. Gerstner, Jr. Scholar and a Velocity Fellow by Columbia University Vagelos College of Physicians and Surgeons. Dr. Izar is a member of the American Association for Cancer Research, the American Society of Clinical Oncology, the Society for Immunotherapy of Cancer, and the Society for Melanoma Research.

Biography: Dr. Stergios Zacharoulis, MD is an Oncology Specialist who practices in New York, NY. He is 55 years old and has been practicing for 30 years. Dr. Stergios Zacharoulis, MD is affiliated with Newyork-Presbyterian/Columbia University Medical Center and Newyork-Presbyterian/Morgan Stanley Children's Hospital.

Care Philosophy: Augusta University Health is a world class health care network offering the most comprehensive care in the region where your health is our priority As leaders in patient and family centered care our physicians partner with our patients their famil

Biography: Mariam El-Ashmawy, MD PhD is a medical oncologist andtranslational scientist with specialization in the treatment of advanced skincancer and ocular melanoma. Her research investigates the complex geneticlandscape of cancer in order to develop new therapies. In the laboratory, her work has been dedicated to understanding the complex genomic landscape of cancer and developing novel targeted therapeutic strategies. Her ongoing projects include testing novel RAS pathway inhibitors in preclinical models of gastric and esophageal cancer as well as a first-in-human clinical trials for patients with NRAS mutant melanoma.

Biography: Kimberly Nojima, NP is an Oncology Specialist who practices in New York, NY. Kimberly Nojima, NP is affiliated with Newyork-Presbyterian/Columbia University Medical Center.

Care Philosophy: We are committed to delivering the best care and an exceptional patient experience We are devoted to providing services that are patient centered and compassionate and care for you as a person nbsp;